Monday, 18 April 2011

Depakote




In the US, Depakote (divalproex sodium systemic) is a member of the drug class fatty acid derivative anticonvulsants and is used to treat Bipolar Disorder, Epilepsy, Mania and Migraine Prevention.

US matches:

  • Depakote

  • Depakote Delayed-Release Tablets

  • Depakote ER Extended-Release Tablets

  • Depakote Sprinkle Capsules

  • Depakote ER

  • Depakote Sprinkles

  • Depakote DR

  • Depakote Capsules

UK matches:

  • Depakote tablets (SPC)

Ingredient matches for Depakote



Valproic Acid

Valproic Acid semisodium (a derivative of Valproic Acid) is reported as an ingredient of Depakote in the following countries:


  • Antigua & Barbuda

  • Aruba

  • Bahamas

  • Barbados

  • Bermuda

  • Brazil

  • Cayman Islands

  • Grenada

  • Guyana

  • Haiti

  • Indonesia

  • Jamaica

  • Luxembourg

  • Netherlands Antilles

  • Philippines

  • Saint Lucia

  • Saint Vincent & The Grenadines

  • Suriname

  • Trinidad & Tobago

  • Turks & Caicos Islands

  • United Kingdom

  • United States

  • Virgin Islands (British)

Valproic Acid sodium (a derivative of Valproic Acid) is reported as an ingredient of Depakote in the following countries:


  • United Kingdom

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

No comments:

Post a Comment